Marfan research shifts attention to tissue outside the vessel wall
Researchers in Spain have reported evidence that the fatty tissue surrounding the aorta is not merely structural padding in Marfan syndrome, but an active participant in vascular behavior. The work, led by investigators at the Autonomous University of Barcelona and the cardiovascular research network CIBERCV, examined how perivascular adipose tissue, or PVAT, affects the aorta in a murine model of the inherited disorder.
The findings add a new layer to how scientists think about cardiovascular risk in Marfan syndrome. The condition is caused by changes in the fibrillin-1 gene and is one of the most common inherited connective tissue disorders. Its most dangerous complications often involve the aorta, whose wall can progressively weaken and enlarge, raising the risk of tears or rupture. Most research has focused on the vessel wall itself. This study instead looks at the tissue wrapped around it.
According to the researchers, that surrounding fat appears to influence how strongly the aorta contracts, and the effect varies depending on which section of the vessel is studied, the age of the animals, and whether they are male or female. In other words, the biology of Marfan-related vascular disease may depend not only on what is happening inside the artery, but also on the local environment around it.
What the team found in mice
The study, published in Biochemical Pharmacology, used a mouse model of Marfan syndrome to compare different regions of the aorta across sexes and ages. The researchers found that PVAT altered contractile responses in ways that were not uniform throughout the vessel.
One of the clearest observations involved females with Marfan syndrome. In those animals, PVAT reduced the force with which the ascending aorta contracted. The source text links that effect to cellular mechanisms associated with oxidative balance, suggesting that biochemical signaling in the surrounding tissue may help shape vascular tone.
That matters because the ascending aorta is one of the most clinically important segments in Marfan syndrome. It is a frequent site of progressive dilation and a major focus of surveillance and treatment. If the tissue around that region contributes to how the vessel responds to disease-related stress, it could help explain why damage does not evolve identically across the entire aorta.
The researchers also emphasize that sex differences deserve more attention. Marfan syndrome affects men and women at similar rates, but evidence has been building that the course of cardiovascular complications may not be identical. This study supports that broader idea by showing that the impact of PVAT is not the same in all animals.
Why the findings matter
The study does not claim to overturn the core understanding of Marfan syndrome, nor does it present a new therapy ready for patients. It is a preclinical investigation in mice. Even so, it points to a potentially important shift in emphasis: vascular disease in Marfan syndrome may be shaped by interactions between the aortic wall and neighboring tissues rather than by wall defects alone.
That is relevant for two reasons. First, it suggests that researchers may need more region-specific models of the disease. The aorta is not a single uniform tube. Different segments face different mechanical stresses and may respond differently to the same genetic defect. If PVAT behaves differently in separate anatomical regions, then generalized explanations of aortic dysfunction may miss clinically meaningful distinctions.
Second, the data reinforce the need to include sex as a biological variable in cardiovascular research. Historically, many mechanistic studies have not been designed to capture those differences in depth. Here, the influence of PVAT was tied not just to anatomy, but also to whether the animals were male or female. That makes the surrounding adipose tissue a possible contributor to divergent disease patterns rather than a neutral bystander.
The work also reflects a larger trend in vascular biology. Adipose tissue near blood vessels is increasingly understood as metabolically active tissue that releases signaling molecules and can influence inflammation, oxidative stress, and vessel tone. In Marfan syndrome, where connective tissue abnormalities already leave the aorta vulnerable, that added signaling layer could become especially important.
What this does and does not show
The main limitation is translation. Results in mouse models can reveal mechanisms, but they do not automatically predict patient outcomes. The study supports the idea that PVAT participates in vascular regulation in Marfan syndrome, but it does not establish how large that contribution is in humans or whether targeting it would reduce aneurysm progression or prevent acute aortic events.
It also leaves open practical questions. If PVAT plays different roles by vessel segment and sex, future work will need to determine which molecular pathways are driving those differences and whether they can be measured or modified safely. That is a much longer path than identifying an effect in an experimental model.
Still, the study has value because it reframes part of the problem. Instead of seeing the aorta in Marfan syndrome only as a structurally compromised vessel, it encourages researchers to consider the local tissue ecosystem around it. For a disease in which early detection and careful monitoring are critical, sharper biological understanding can eventually help guide risk stratification and treatment development.
For now, the strongest takeaway is that the fat surrounding the aorta appears biologically active in Marfan syndrome, and its effects are not one-size-fits-all. Anatomy, age, and sex all appear to matter. That makes the findings less of a simple headline about fat and more of a targeted insight into how a complex inherited vascular disease may operate.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
